National Health Investors, Inc. provided earnings guidance for the full year 2022. For the period, the company expected net income attributable to common stockholders to be in the range of $88.2 million to $90 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.04 USD | -1.14% | -2.82% | +14.66% |
May. 29 | Declaration of Voting Results by National Health Investors | CI |
May. 09 | Land & Buildings Investment Management Comments on National Health Investors? Supplemental Proxy Statement | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.66% | 2.81B | |
+11.61% | 60.29B | |
-4.88% | 19.06B | |
+0.39% | 7.69B | |
-9.17% | 5.94B | |
+11.44% | 3.58B | |
-1.23% | 3.3B | |
-7.62% | 3.1B | |
+1.43% | 3.07B | |
-17.37% | 2.4B |
- Stock Market
- Equities
- NHI Stock
- News National Health Investors, Inc.
- National Health Investors, Inc. Provides Earnings Guidance for the Full Year 2022